Life ScienceCompany
Kaken Pharmaceutical M&A Summary
Kaken Pharmaceutical has acquired 1 company, including 1 in the last 5 years.
Kaken Pharmaceutical’s largest acquisition to date was in 2025, when it acquired Aadi Subsidiary for $100M. Kaken Pharmaceutical has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Kaken Pharmaceutical Business Overview
Where is Kaken Pharmaceutical headquartered?
Kaken Pharmaceutical is headquartered in Tokyo, Japan.
What is Kaken Pharmaceutical’s revenue?
Kaken Pharmaceutical disclosed revenue of 72,044M JPY for 2024 and 72,984M JPY for 2023.
How many employees does Kaken Pharmaceutical have?
Kaken Pharmaceutical has 1,143 employees.
What sector is Kaken Pharmaceutical in?
Kaken Pharmaceutical is a life science company.
When was Kaken Pharmaceutical founded?
Kaken Pharmaceutical was founded in 1948.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
Unlimited Searches
